Michaela Liedtke

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Noopur Raje, Jesús G. Berdeja, Yi Lin et al. · New England Journal of Medicine · 2019 · 1.7K citations · Full text

Medicine, Immunology, Oncology +17

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia

Hagop M. Kantarjian, Daniel J. DeAngelo, Matthias Stelljes et al. · New England Journal of Medicine · 2016 · 1.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

Ujjawal H. Gandhi, Robert F. Cornell, Arjun Lakshman et al. · Leukemia · 2019 · 616 citations

Medicine, Hematology, Oncology +13

Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia

Jeffrey M. Granja, Sandy Klemm, Lisa McGinnis et al. · Nature Biotechnology · 2019 · 566 citations · Full text

Life Sciences, Bioinformatics, Cell Biology +12

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

Wendy Stock, Selina M. Luger, Anjali S. Advani et al. · Blood · 2019 · 471 citations · Full text

Medicine, Oncology, Pediatrics +9